GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » SILO Pharma Inc (NAS:SILO) » Definitions » E10

SILO (SILO Pharma) E10 : $-1.33 (As of Sep. 2024)


View and export this data going back to 2012. Start your Free Trial

What is SILO Pharma E10?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

SILO Pharma's adjusted earnings per share data for the three months ended in Sep. 2024 was $-0.220. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is $-1.33 for the trailing ten years ended in Sep. 2024.

During the past 3 years, the average E10 Growth Rate was -11.20% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

During the past 13 years, the highest 3-Year average E10 Growth Rate of SILO Pharma was -11.20% per year. The lowest was -11.20% per year. And the median was -11.20% per year.

As of today (2024-12-13), SILO Pharma's current stock price is $0.84. SILO Pharma's E10 for the quarter that ended in Sep. 2024 was $-1.33. SILO Pharma's Shiller PE Ratio of today is .


SILO Pharma E10 Historical Data

The historical data trend for SILO Pharma's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

SILO Pharma E10 Chart

SILO Pharma Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only - -0.91 -0.86 -1.09 -1.25

SILO Pharma Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.20 -1.25 -1.37 -1.35 -1.33

Competitive Comparison of SILO Pharma's E10

For the Biotechnology subindustry, SILO Pharma's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


SILO Pharma's Shiller PE Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, SILO Pharma's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where SILO Pharma's Shiller PE Ratio falls into.



SILO Pharma E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, SILO Pharma's adjusted earnings per share data for the three months ended in Sep. 2024 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Sep. 2024 (Change)*Current CPI (Sep. 2024)
=-0.22/133.0289*133.0289
=-0.220

Current CPI (Sep. 2024) = 133.0289.

SILO Pharma Quarterly Data

per share eps CPI Adj_EPS
201412 -0.135 99.070 -0.181
201503 0.028 99.621 0.037
201506 0.016 100.684 0.021
201509 -0.456 100.392 -0.604
201512 0.000 99.792 0.000
201603 -0.103 100.470 -0.136
201606 -0.434 101.688 -0.568
201609 -0.431 101.861 -0.563
201612 -0.143 101.863 -0.187
201703 0.500 102.862 0.647
201706 -0.076 103.349 -0.098
201709 -0.518 104.136 -0.662
201712 0.207 104.011 0.265
201803 0.017 105.290 0.021
201806 -0.500 106.317 -0.626
201809 -0.198 106.507 -0.247
201812 -0.500 105.998 -0.628
201903 -0.500 107.251 -0.620
201906 -0.500 108.070 -0.615
201909 -0.500 108.329 -0.614
201912 -0.500 108.420 -0.613
202003 -0.500 108.902 -0.611
202006 -2.000 108.767 -2.446
202009 -0.500 109.815 -0.606
202012 -0.500 109.897 -0.605
202103 -1.500 111.754 -1.786
202106 -0.238 114.631 -0.276
202109 3.160 115.734 3.632
202112 -0.380 117.630 -0.430
202203 -0.310 121.301 -0.340
202206 -0.330 125.017 -0.351
202209 -0.490 125.227 -0.521
202212 -0.580 125.222 -0.616
202303 -0.290 127.348 -0.303
202306 -0.320 128.729 -0.331
202309 -0.210 129.860 -0.215
202312 -0.380 129.419 -0.391
202403 -0.280 131.776 -0.283
202406 -0.310 132.554 -0.311
202409 -0.220 133.029 -0.220

Add all the adjusted EPS together and divide 10 will get our e10.


SILO Pharma  (NAS:SILO) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


SILO Pharma E10 Related Terms

Thank you for viewing the detailed overview of SILO Pharma's E10 provided by GuruFocus.com. Please click on the following links to see related term pages.


SILO Pharma Business Description

Traded in Other Exchanges
N/A
Address
677 N. Washington Boulevard, Sarasota, FL, USA, 34236
SILO Pharma Inc is a developmental stage biopharmaceutical company developing novel therapeutics that address underserved conditions including stress-induced psychiatric disorders, chronic pain conditions, and central nervous system (CNS) diseases. It focuses on developing traditional therapies and psychedelic treatments in novel formulations and drug delivery systems. The company's lead program, SPC-15, is an intranasal treatment targeting PTSD and stress-induced anxiety disorders.
Executives
Eric Weisblum director, officer: President and CCO 285 GRAND AVENUE, ENGLEWOOD NJ 07631
Daniel E. Ryweck officer: Chief Financial Officer 712 VISTA BLVD #305, WACONIA MN 55387
Jeff Pavell director 1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK NY 10020
Kevin Munoz director 560 SYLVAN AVE, SUITE 3160, ENGLEWOOD CLIFF NJ 07632
Wayne Linsley director 1 ROCKEFELLER PLAZA, SUITE 1039, NEW YORK NY 10020
Adam C Wasserman officer: Chief Financial Officer 1643 ROYAL GROVE WAY, WESTON FL 33327
Leonard M Schiller director
Joel Alan Stone, director 1772 SABAL PALM DR., BOCA RATON FL 33432
Parker Walter Van Eps director C/O PROSPECT ENERGY CORPORATION, 10 E. 40TH STREET, 44TH FLOOR, NEW YORK NY 10016
Richard Brand director, officer: Chairman and CEO 10 E. 40TH STREET, 44TH FLOOR, NEW YORK NY 10016
Whalehaven Capital Fund Ltd 10 percent owner P O BOX HM 1027, HAMILTON D0 HMDX
Vadim Mats officer: VP of Business Development 285 GRAND AVENUE, ENGLEWOOD NJ 07631
Donald Ptalis director, officer: CFO 72 POND ROAD, WOODBURY NY 11797
Melvin Schlossberg director, 10 percent owner, officer: PRESIDENT, CEO & SECRETARY 72 POND ROAD, WOODBURY NY 11797